Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle
- PMID: 12563012
- PMCID: PMC2342583
- DOI: 10.1113/jphysiol.2002.029306
Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle
Abstract
Myosin phosphatase (MLCP) plays a critical regulatory role in the Ca(2+) sensitivity of myosin phosphorylation and smooth muscle contraction. It has been suggested that phosphorylation at Thr(695) of the MLCP regulatory subunit (MYPT1) and at Thr(38) of the MLCP inhibitor protein CPI-17 results in inhibition of MLCP activity. We have previously demonstrated that CPI-17 Thr(38) phosphorylation plays an important role in G-protein-mediated inhibition of MLCP in tonic arterial smooth muscle. Here, we attempted to evaluate the function of MYPT1 in phasic rabbit portal vein (PV) and vas deferens (VD) smooth muscles. Using site- and phospho-specific antibodies, phosphorylation of MYPT1 Thr(695) and CPI-17 Thr(38) was examined along with MYPT1 Thr(850), which is a non-inhibitory Rho-kinase site. We found that both CPI-17 Thr(38) and MYPT1 Thr(850) were phosphorylated in response to agonists or GTPgammaS concurrently with contraction and myosin phosphorylation in alpha-toxin-permeabilized PV tissues. In contrast, phosphorylation of MYPT1 Thr(695) did not increase. Comparable results were also obtained in both permeabilized and intact VD. The Rho-kinase inhibitor Y-27632 and the protein kinase C (PKC) inhibitor GF109203X suppressed phosphorylation of MYPT1 Thr(850) and CPI-17 Thr(38), respectively, in intact VD while MYPT1 Thr(695) phosphorylation was insensitive to both inhibitors. These results indicate that phosphorylation of MYPT1 Thr(695) is independent of stimulation of G-proteins, Rho-kinase or PKC. In the phasic PV, phosphorylation of CPI-17 Thr(38) may contribute towards inhibition of MLCP while the phasic visceral VD, which has a low CPI-17 concentration, probably utilizes other Ca(2+) sensitizing mechanisms for inhibiting MLCP besides phosphorylation of MYPT1 and CPI-17.
Figures
Similar articles
-
Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle.J Physiol. 2001 Sep 1;535(Pt 2):553-64. doi: 10.1111/j.1469-7793.2001.t01-1-00553.x. J Physiol. 2001. PMID: 11533144 Free PMC article.
-
Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.J Biol Chem. 2000 Apr 7;275(14):9897-900. doi: 10.1074/jbc.275.14.9897. J Biol Chem. 2000. PMID: 10744661
-
Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms.J Biol Chem. 2001 Aug 3;276(31):29072-8. doi: 10.1074/jbc.M103206200. Epub 2001 Jun 7. J Biol Chem. 2001. PMID: 11397799
-
Protein kinase network in the regulation of phosphorylation and dephosphorylation of smooth muscle myosin light chain.Mol Cell Biochem. 2003 Jun;248(1-2):105-14. doi: 10.1023/a:1024180101032. Mol Cell Biochem. 2003. PMID: 12870661 Review.
-
Rho-Mancing to Sensitize Calcium Signaling for Contraction in the Vasculature: Role of Rho Kinase.Adv Pharmacol. 2017;78:303-322. doi: 10.1016/bs.apha.2016.09.001. Epub 2016 Oct 27. Adv Pharmacol. 2017. PMID: 28212799 Review.
Cited by
-
Calponin 1 inhibits agonist-induced ERK activation and decreases calcium sensitization in vascular smooth muscle.J Cell Mol Med. 2024 Jan;28(1):e18025. doi: 10.1111/jcmm.18025. Epub 2023 Dec 26. J Cell Mol Med. 2024. PMID: 38147352 Free PMC article.
-
Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.Hypertens Res. 2022 Jan;45(1):40-52. doi: 10.1038/s41440-021-00733-y. Epub 2021 Oct 6. Hypertens Res. 2022. PMID: 34616031 Review.
-
Mfge8 attenuates human gastric antrum smooth muscle contractions.J Muscle Res Cell Motil. 2021 Jun;42(2):219-231. doi: 10.1007/s10974-021-09604-y. Epub 2021 Jun 3. J Muscle Res Cell Motil. 2021. PMID: 34085177 Free PMC article.
-
MicroRNA Regulatory Pathways in the Control of the Actin-Myosin Cytoskeleton.Cells. 2020 Jul 9;9(7):1649. doi: 10.3390/cells9071649. Cells. 2020. PMID: 32660059 Free PMC article. Review.
-
RhoA/Rho-kinases in asthma: from pathogenesis to therapeutic targets.Clin Transl Immunology. 2020 Apr 29;9(5):e01134. doi: 10.1002/cti2.1134. eCollection 2020 May. Clin Transl Immunology. 2020. PMID: 32355562 Free PMC article. Review.
References
-
- Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) J Biol Chem. 1996;271:20246–20249. - PubMed
-
- Borman MA, MacDonald JA, Murányi A, Hartshorne DJ, Haystead TA. Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition. J Biol Chem. 2002;277:23441–23446. - PubMed
-
- Burnstock G. Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol. 1995;46:365–384. - PubMed
-
- Butler TM, Narayan SR, Mooers Su, Siegman MJ. Rapid turnover of myosin light chain phosphate during cross-bridge cycling in smooth muscle. Am J Physiol. 1994;36:C1160–1166. - PubMed
-
- Chen YH, Chen MX, Alessi DR, Campbell DG, Shanahan C, Cohen P, Cohen PTW. Molecular cloning of cDNA encoding the 110 kDa and 21 kDa regulatory subunits of smooth muscle protein phosphatase 1M. FEBS Lett. 1994;356:51–55. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous